Evidence map›Paper›PMID 25564611›Full record

ArticleThe Journal of biological chemistry2015

Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity.

Maxime Lecerf, Tobias Scheel, Anastas D Pashov, Annaelle Jarossay, Delphine Ohayon, Cyril Planchais, Stephane Mesnage, Claudia Berek, Srinivas V Kaveri, Sébastien Lacroix-Desmazes and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Is haem the real target of COVID-19?Photodiagnosis and photodynamic therapy · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Maxime LecerfFrom the Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, UMR S 1138, F-75006 Paris, France,; the Université Paris Descartes, UMR S 1138, F-75006 Paris, France,; INSERM U1138, F-75006 Paris, France.
Tobias Scheelthe Deutsches Rheuma-Forschungszentrum, Institut der Leibniz-Gemeinschaft, 10117 Berlin, Germany.
Anastas D Pashovthe Institute of Microbiology, Bulgarian Academy of Sciences, Sofia 1113, Bulgaria, and.
Annaelle JarossayFrom the Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, UMR S 1138, F-75006 Paris, France,; the Université Paris Descartes, UMR S 1138, F-75006 Paris, France,; INSERM U1138, F-75006 Paris, France.
Delphine OhayonFrom the Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, UMR S 1138, F-75006 Paris, France,; the Université Paris Descartes, UMR S 1138, F-75006 Paris, France,; INSERM U1138, F-75006 Paris, France.
Cyril PlanchaisFrom the Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, UMR S 1138, F-75006 Paris, France,; the Université Paris Descartes, UMR S 1138, F-75006 Paris, France,; INSERM U1138, F-75006 Paris, France.
Stephane Mesnagethe Krebs Institute, University of Sheffield, Firth Court, Western Bank, Sheffield S10 2TN, United Kingdom.
Claudia Berekthe Deutsches Rheuma-Forschungszentrum, Institut der Leibniz-Gemeinschaft, 10117 Berlin, Germany.
Srinivas V KaveriFrom the Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, UMR S 1138, F-75006 Paris, France,; the Université Paris Descartes, UMR S 1138, F-75006 Paris, France,; INSERM U1138, F-75006 Paris, France.
Sébastien Lacroix-DesmazesFrom the Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, UMR S 1138, F-75006 Paris, France,; the Université Paris Descartes, UMR S 1138, F-75006 Paris, France,; INSERM U1138, F-75006 Paris, France.
Jordan D DimitrovFrom the Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, UMR S 1138, F-75006 Paris, France,; the Université Paris Descartes, UMR S 1138, F-75006 Paris, France,; INSERM U1138, F-75006 Paris, France,. Electronic address: jordan.dimitrov@crc.jussieu.fr.
Délégation Paris 5 · FRLeibniz Association · DEBulgarian Academy of Sciences · BGUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The healthy immune repertoire contains a fraction of antibodies that bind to various biologically relevant cofactors, including heme. Interaction of heme with some antibodies results in induction of new antigen binding specificities and acquisition of binding polyreactivity. In vivo, extracellular heme is released as a result of hemolysis or tissue damage; hence the post-translational acquisition of novel antigen specificities might play an important role in the diversification of the immunoglobulin repertoire and host defense. Here, we demonstrate that seronegative immune repertoires contain antibodies that gain reactivity to HIV-1 gp120 upon exposure to heme. Furthermore, a panel of human recombinant antibodies was cloned from different B cell subpopulations, and the prevalence of antibodies with cofactor-induced specificity for gp120 was determined. Our data reveal that upon exposure to heme, ∼24% of antibodies acquired binding specificity for divergent strains of HIV-1 gp120. Sequence analyses reveal that heme-sensitive antibodies do not differ in their repertoire of variable region genes and in most of the molecular features of their antigen-binding sites from antibodies that do not change their antigen binding specificity. However, antibodies with cofactor-induced gp120 specificity possess significantly lower numbers of somatic mutations in their variable region genes. This study contributes to the understanding of the significance of cofactor-binding antibodies in immunoglobulin repertoires and of the influence that the tissue microenvironment might have in shaping adaptive immune responses.

Indexed as

HIV AntibodiesImmunoglobulin Variable RegionAdaptive ImmunityB-LymphocytesHIV-1HIV Envelope Protein gp120Humansgp120 protein, Human immunodeficiency virus 1HIV AntibodiesHIV Envelope Protein gp120Immunoglobulin Variable RegionAntibodyCloningCofactorsgp120HemeHuman Immunodeficiency Virus (HIV)Immunoglobulin G (IgG)

Identifiers

PMID25564611
PMCPMC4335253
OpenAlexW2029041254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.